Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients
- PMID: 11797115
- DOI: 10.1007/s002770100371
Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients
Abstract
The object was to analyze, in a nationwide survey, the incidence and course of hereditary hemochromatosis in relation to the degree of iron overload and the presence of organ damage. The study included 179 Danish Caucasian patients with clinically overt hemochromatosis diagnosed between 1948 and 1985. A cohort of 158 patients was followed for a median of 8.5 years (range: 0.2-29.5). From 1951 to 1975, the yearly relative incidence rate was constant: 0.58/100,000 persons >20 years of age. From 1981 to 1985, the yearly relative incidence rate rose to 1.40/100,000 persons >20 years of age. Survival was reduced in the entire series when compared with a matched control population ( p<0.0001). There was a steady increase in survival from 1948 to 1985 ( p<0.002). Survival was significantly reduced in patients with liver cirrhosis and/or diabetes mellitus ( p<0.01). In contrast, survival in patients without cirrhosis or diabetes was similar to rates expected. Survival in patients with arthropathy was higher than in patients without joint affection ( p<0.004). Patients adequately treated with phlebotomy ( n=66) had a higher survival than inadequately treated patients ( n=62; p<0.0001). Adequately treated patients with cirrhosis and/or diabetes had better survival than inadequately treated patients with similar organ damage ( p<0.001). The main causes of death were hepatic failure due to cirrhosis (32.0%) and cirrhosis with liver cancer (23.1%). Sharpened diagnostic awareness has improved early diagnosis and increased the diagnostic frequency of clinical hemochromatosis. Adequate phlebotomy treatment was the major determinant of survival and markedly improved prognosis. Early detection and treatment of this common iron overload disorder is crucial and can completely prevent any excess mortality caused by hemochromatosis.
Similar articles
-
Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis.N Engl J Med. 1985 Nov 14;313(20):1256-62. doi: 10.1056/NEJM198511143132004. N Engl J Med. 1985. PMID: 4058506
-
Long term results of venesection therapy in idiopathic haemochromatosis.Q J Med. 1976 Oct;45(180):611-23. Q J Med. 1976. PMID: 188063
-
Long-term survival in patients with hereditary hemochromatosis.Gastroenterology. 1996 Apr;110(4):1107-19. doi: 10.1053/gast.1996.v110.pm8613000. Gastroenterology. 1996. PMID: 8613000
-
[Idiopathic hemochromatosis].Minerva Med. 1985 Mar 31;76(13):627-34. Minerva Med. 1985. PMID: 2986052 Review. Italian.
-
[Iron storage disease].Orv Hetil. 2004 Sep 26;145(39):1979-84. Orv Hetil. 2004. PMID: 15553908 Review. Hungarian.
Cited by
-
Impact of HFE genetic testing on clinical presentation of hereditary hemochromatosis: new epidemiological data.BMC Med Genet. 2005 Jun 1;6:24. doi: 10.1186/1471-2350-6-24. BMC Med Genet. 2005. PMID: 15929798 Free PMC article.
-
Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management.World J Gastroenterol. 2020 Jun 7;26(21):2740-2757. doi: 10.3748/wjg.v26.i21.2740. World J Gastroenterol. 2020. PMID: 32550751 Free PMC article. Review.
-
Clinical-Pathological Conference Series from the Medical University of Graz : Case No 159: 52-year-old patient with psoriasis and arthralgia of the finger joints.Wien Klin Wochenschr. 2016 Nov;128(21-22):846-853. doi: 10.1007/s00508-016-1010-0. Epub 2016 Jun 30. Wien Klin Wochenschr. 2016. PMID: 27363994 Free PMC article. No abstract available.
-
Iron and cancer: more ore to be mined.Nat Rev Cancer. 2013 May;13(5):342-55. doi: 10.1038/nrc3495. Epub 2013 Apr 18. Nat Rev Cancer. 2013. PMID: 23594855 Free PMC article. Review.
-
Free iron status & insulin resistance in type 2 diabetes mellitus: Analyzing the probable role of a peanut protein.Indian J Med Res. 2015 Nov;142(5):606-9. doi: 10.4103/0971-5916.171291. Indian J Med Res. 2015. PMID: 26658597 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical